Cargando…

Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study

BACKGROUND: Magnetic resonance arthrography (MRA) requires intra-articular injection of gadolinium-based diluted paramagnetic contrast material. To our knowledge, gadobenate dimeglumine (Gd-BOPTA) has never been used for intra-articular applications. Our aim was to test in vitro different concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Messina, Carmelo, Albano, Domenico, Orlandi, Davide, Chianca, Vito, Corazza, Angelo, Ferrari, Federica, Gitto, Salvatore, Sconfienza, Luca Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815038/
https://www.ncbi.nlm.nih.gov/pubmed/31653206
http://dx.doi.org/10.1186/s12880-019-0387-4
_version_ 1783463118453604352
author Messina, Carmelo
Albano, Domenico
Orlandi, Davide
Chianca, Vito
Corazza, Angelo
Ferrari, Federica
Gitto, Salvatore
Sconfienza, Luca Maria
author_facet Messina, Carmelo
Albano, Domenico
Orlandi, Davide
Chianca, Vito
Corazza, Angelo
Ferrari, Federica
Gitto, Salvatore
Sconfienza, Luca Maria
author_sort Messina, Carmelo
collection PubMed
description BACKGROUND: Magnetic resonance arthrography (MRA) requires intra-articular injection of gadolinium-based diluted paramagnetic contrast material. To our knowledge, gadobenate dimeglumine (Gd-BOPTA) has never been used for intra-articular applications. Our aim was to test in vitro different concentrations of Gd-BOPTA to be potentially used to perform MRA. METHODS: Gd-BOPTA was diluted in saline (NaCl 0.9%) to achieve different concentrations (4 mmol/l; 2 mmol/l; 1 mmol/l; 0.67 mmol/l; 0.5 mmol/l). Six sets of five sterile pipes were prepared with 5 ml of each solution, five sets added with 0.5 ml of fresh synovial fluid. Two separate pipes were prepared with 5 ml of gadopentetate dimeglumine (Gd-DTPA) at 2 mmol/l, one pipe added with 0.5 ml of synovial fluid. Pipes were imaged using a T1-weighted sequence at 1.5 T. For each pipe, signal intensity (SI) in arbitrary units (au) was measured. RESULTS: SI reproducibility range was 86–99%. Mean Gd-BOPTA SI in pipes containing synovial fluid increased from 1236 ± 8au (0.5 mmol/l) up to 1610 ± 44au (1 mmol/l) and down to 1405 ± 33au (4 mmol/l). Mean Gd-BOPTA SI in pipes without synovial fluid increased from 1184 ± 29au (0.5 mmol/l) up to 1530 ± 38au (1 mmol/l), and down to 1347 ± 39au (4 mmol/l). SI of pipes without synovial fluid was lower than that of pipes with synovial fluid for both Gd-BOPTA and Gd-DTPA (P ≤ 0.002). Regarding pipes with synovial fluid, mean Gd-DTPA SI at 2 mmol/l was 1246 ± 27au. Compared with Gd-BOPTA, SI was not different at 0.5 mmol/l (− 0.2%, P = 0.587) while it was higher (P < 0.001) at all other concentrations (range + 13.3%[4 mmol/l] − + 28.3%[1 mmol/l]). Regarding pipes without synovial fluid, mean Gd-DTPA SI at 2 mmol/l was 1275 ± 56au. Compared with Gd-BOPTA, SI was lower at 0.5 mmol/l (− 6.8%,P < 0.001), while it was higher (P < 0.001) at all other concentrations (range + 6.1%[4 mmol/l] − + 19.6% [1 mmol/l]). CONCLUSIONS: In vitro, Gd-BOPTA at 1 mmol/ had a + 28% SI increase in comparison to Gd-DTPA 2 mmol/l. SI similar to Gd-DTPA can be obtained using one fourth concentration of Gd-BOPTA.
format Online
Article
Text
id pubmed-6815038
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68150382019-10-31 Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study Messina, Carmelo Albano, Domenico Orlandi, Davide Chianca, Vito Corazza, Angelo Ferrari, Federica Gitto, Salvatore Sconfienza, Luca Maria BMC Med Imaging Research Article BACKGROUND: Magnetic resonance arthrography (MRA) requires intra-articular injection of gadolinium-based diluted paramagnetic contrast material. To our knowledge, gadobenate dimeglumine (Gd-BOPTA) has never been used for intra-articular applications. Our aim was to test in vitro different concentrations of Gd-BOPTA to be potentially used to perform MRA. METHODS: Gd-BOPTA was diluted in saline (NaCl 0.9%) to achieve different concentrations (4 mmol/l; 2 mmol/l; 1 mmol/l; 0.67 mmol/l; 0.5 mmol/l). Six sets of five sterile pipes were prepared with 5 ml of each solution, five sets added with 0.5 ml of fresh synovial fluid. Two separate pipes were prepared with 5 ml of gadopentetate dimeglumine (Gd-DTPA) at 2 mmol/l, one pipe added with 0.5 ml of synovial fluid. Pipes were imaged using a T1-weighted sequence at 1.5 T. For each pipe, signal intensity (SI) in arbitrary units (au) was measured. RESULTS: SI reproducibility range was 86–99%. Mean Gd-BOPTA SI in pipes containing synovial fluid increased from 1236 ± 8au (0.5 mmol/l) up to 1610 ± 44au (1 mmol/l) and down to 1405 ± 33au (4 mmol/l). Mean Gd-BOPTA SI in pipes without synovial fluid increased from 1184 ± 29au (0.5 mmol/l) up to 1530 ± 38au (1 mmol/l), and down to 1347 ± 39au (4 mmol/l). SI of pipes without synovial fluid was lower than that of pipes with synovial fluid for both Gd-BOPTA and Gd-DTPA (P ≤ 0.002). Regarding pipes with synovial fluid, mean Gd-DTPA SI at 2 mmol/l was 1246 ± 27au. Compared with Gd-BOPTA, SI was not different at 0.5 mmol/l (− 0.2%, P = 0.587) while it was higher (P < 0.001) at all other concentrations (range + 13.3%[4 mmol/l] − + 28.3%[1 mmol/l]). Regarding pipes without synovial fluid, mean Gd-DTPA SI at 2 mmol/l was 1275 ± 56au. Compared with Gd-BOPTA, SI was lower at 0.5 mmol/l (− 6.8%,P < 0.001), while it was higher (P < 0.001) at all other concentrations (range + 6.1%[4 mmol/l] − + 19.6% [1 mmol/l]). CONCLUSIONS: In vitro, Gd-BOPTA at 1 mmol/ had a + 28% SI increase in comparison to Gd-DTPA 2 mmol/l. SI similar to Gd-DTPA can be obtained using one fourth concentration of Gd-BOPTA. BioMed Central 2019-10-25 /pmc/articles/PMC6815038/ /pubmed/31653206 http://dx.doi.org/10.1186/s12880-019-0387-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Messina, Carmelo
Albano, Domenico
Orlandi, Davide
Chianca, Vito
Corazza, Angelo
Ferrari, Federica
Gitto, Salvatore
Sconfienza, Luca Maria
Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title_full Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title_fullStr Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title_full_unstemmed Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title_short Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
title_sort potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815038/
https://www.ncbi.nlm.nih.gov/pubmed/31653206
http://dx.doi.org/10.1186/s12880-019-0387-4
work_keys_str_mv AT messinacarmelo potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT albanodomenico potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT orlandidavide potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT chiancavito potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT corazzaangelo potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT ferrarifederica potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT gittosalvatore potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy
AT sconfienzalucamaria potentialuseofadilutedhighrelaxivitygadoliniumbasedintraarticularcontrastagentformagneticresonancearthrographyaninvitrostudy